Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugen Verspohl

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Medizinische Monatsschrift Fur Pharmazeuten|July 7, 2018
[In process]Eugen Verspohl
Medizinische Monatsschrift Fur Pharmazeuten|July 7, 2018
[In process]Eugen Verspohl
Medizinische Monatsschrift Fur Pharmazeuten|June 29, 2018
[In process]Eugen Verspohl
Medizinische Monatsschrift Fur Pharmazeuten|July 10, 2018
[In process]Eugen Verspohl
Medizinische Monatsschrift Fur Pharmazeuten|July 7, 2018
[In process]Eugen Verspohl
Journal of Pharmaceutical and Biomedical Analysis|September 18, 2013
Metabolism studies of ifenprodil, a potent GluN2B receptor antagonistEvamaria Falck, Frank Begrow, Eugen Verspohl, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Medizinische Monatsschrift Fur Pharmazeuten|July 7, 2018
[In process]Eugen Verspohl
Medizinische Monatsschrift Fur Pharmazeuten|July 7, 2018
[In process]Eugen Verspohl
Medizinische Monatsschrift Fur Pharmazeuten|June 29, 2018
[In process]Eugen Verspohl
Medizinische Monatsschrift Fur Pharmazeuten|July 10, 2018
[In process]Eugen Verspohl
Medizinische Monatsschrift Fur Pharmazeuten|July 7, 2018
[In process]Eugen Verspohl
Journal of Pharmaceutical and Biomedical Analysis|September 18, 2013
Metabolism studies of ifenprodil, a potent GluN2B receptor antagonistEvamaria Falck, Frank Begrow, Eugen Verspohl, et al.
Pageof 1